SYDNEY (Reuters) – Australia’s medical regulator said on Tuesday it had granted provisional approval for the COVID-19 vaccine developed by AstraZeneca, making it the second vaccine to get regulatory approval in Australia.
The regulator last month approved the Pfizer-BioNTech COVID-19 vaccine for use and inoculations for its 25 million population will begin from Feb. 22.
(Reporting by Renju Jose; Editing by Jacqueline Wong)
Defending champion Golden Knights beat Stars 3-1 to take 2-0 series lead home to Vegas
Shai Gilgeous-Alexander’s 33 points lead Thunder past Pelicans 124-92 as OKC takes a 2-0 lead
Bruins beat Maple Leafs 4-2 in Game 3 to take series lead
Herro scores 24, Heat hit franchise playoff-record 23 3s to beat Boston and even series 1-1
Shohei Ohtani has 3 doubles, Landon Knack gets 1st victory as Dodgers rout Nationals 11-2
French president will outline his vision for Europe as an assertive global power amid war in Ukraine
Venezuela broke its HPV vaccine promises, and there’s barely any sex ed. Experts say it’s a problem
US coalition warship shoots down missile fired by Yemen’s Houthi rebels over the Gulf of Aden
A look at the Gaza war protests that have emerged on US college campuses
Blinken raises Chinese trade practices in meetings with officials in the financial hub of Shanghai
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
US abortion battle rages on with moves to repeal Arizona ban and a Supreme Court case
US births fell last year, marking an end to the late pandemic rebound, experts say
Relatives of those who died waiting for livers at now halted Houston transplant program seek answers
